Global OTC Anti-Infective Products Competitive Landscape Professional Research Report 2024

Report Format: PDF   |   Report ID: 5685976   |   Published Date: August 2024   |   Pages:  170+  

Research Summary
Over-the-Counter (OTC) Anti-Infective Products are non-prescription medications and remedies available to consumers for the self-treatment of common infections. These products are designed to address a wide range of minor ailments caused by bacteria, viruses, fungi, or other microorganisms, without the need for a doctor's prescription. OTC anti-infective products often include items like antibacterial ointments, antifungal creams, antiviral medications, and other topical solutions to manage conditions such as minor skin infections, cold sores, athlete's foot, and more. They offer convenience and accessibility for consumers to address everyday infections promptly, but individuals should use them with care, following recommended guidelines, and seek professional medical advice when more serious infections or concerns arise.
According to DIResearch's in-depth investigation and research, the global OTC Anti-Infective Products market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of OTC Anti-Infective Products include Bayer, GSK, Teva, Johnson & Johnson, NOVARTIS, Viatris, Sun Pharma, CR SANJIU, Cipla, Lingrui etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of OTC Anti-Infective Products. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global OTC Anti-Infective Products market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the OTC Anti-Infective Products market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of OTC Anti-Infective Products industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of OTC Anti-Infective Products Include:
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
Viatris
Sun Pharma
CR SANJIU
Cipla
Lingrui
OTC Anti-Infective Products Product Segment Include:
Antifungal
Antibacterial
Antiviral
Antiseptics
Others
OTC Anti-Infective Products Product Application Include:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global OTC Anti-Infective Products Industry PESTEL Analysis
Chapter 3: Global OTC Anti-Infective Products Industry Porter's Five Forces Analysis
Chapter 4: Global OTC Anti-Infective Products Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global OTC Anti-Infective Products Market Size and Forecast by Type and Application Analysis
Chapter 6: North America OTC Anti-Infective Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe OTC Anti-Infective Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China OTC Anti-Infective Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) OTC Anti-Infective Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America OTC Anti-Infective Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa OTC Anti-Infective Products Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global OTC Anti-Infective Products Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents

1 OTC Anti-Infective Products Market Overview

1.1 Product Definition and Statistical Scope

1.2 OTC Anti-Infective Products Product by Type

1.2.1 Global OTC Anti-Infective Products Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Antifungal

1.2.3 Antibacterial

1.2.4 Antiviral

1.2.5 Antiseptics

1.2.6 Others

1.3 OTC Anti-Infective Products Product by Application

1.3.1 Global OTC Anti-Infective Products Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global OTC Anti-Infective Products Market Revenue and Sales Analysis

1.4.1 Global OTC Anti-Infective Products Market Size Analysis (2019-2030)

1.4.2 Global OTC Anti-Infective Products Market Sales Analysis (2019-2030)

1.4.3 Global OTC Anti-Infective Products Market Sales Price Trend Analysis (2019-2030)

1.5 OTC Anti-Infective Products Market Development Status and Trends

1.5.1 OTC Anti-Infective Products Industry Development Status Analysis

1.5.2 OTC Anti-Infective Products Industry Development Trends Analysis

2 OTC Anti-Infective Products Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 OTC Anti-Infective Products Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global OTC Anti-Infective Products Market Analysis by Regions

4.1 OTC Anti-Infective Products Overall Market: 2023 VS 2024 VS 2030

4.2 Global OTC Anti-Infective Products Revenue and Forecast Analysis (2019-2030)

4.2.1 Global OTC Anti-Infective Products Revenue and Market Share by Region (2019-2024)

4.2.2 Global OTC Anti-Infective Products Revenue Forecast by Region (2025-2030)

4.3 Global OTC Anti-Infective Products Sales and Forecast Analysis (2019-2030)

4.3.1 Global OTC Anti-Infective Products Sales and Market Share by Region (2019-2024)

4.3.2 Global OTC Anti-Infective Products Sales Forecast by Region (2025-2030)

4.4 Global OTC Anti-Infective Products Sales Price Trend Analysis (2019-2030)

5 Global OTC Anti-Infective Products Market Size by Type and Application

5.1 Global OTC Anti-Infective Products Market Size by Type

5.1.1 Global OTC Anti-Infective Products Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global OTC Anti-Infective Products Sales and Forecast Analysis by Type (2019-2030)

5.2 Global OTC Anti-Infective Products Market Size by Application

5.2.1 Global OTC Anti-Infective Products Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global OTC Anti-Infective Products Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America OTC Anti-Infective Products Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America OTC Anti-Infective Products Market Size by Type

6.3.1 North America OTC Anti-Infective Products Sales by Type (2019-2030)

6.3.2 North America OTC Anti-Infective Products Revenue by Type (2019-2030)

6.4 North America OTC Anti-Infective Products Market Size by Application

6.4.1 North America OTC Anti-Infective Products Sales by Application (2019-2030)

6.4.2 North America OTC Anti-Infective Products Revenue by Application (2019-2030)

6.5 North America OTC Anti-Infective Products Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe OTC Anti-Infective Products Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe OTC Anti-Infective Products Market Size by Type

7.3.1 Europe OTC Anti-Infective Products Sales by Type (2019-2030)

7.3.2 Europe OTC Anti-Infective Products Revenue by Type (2019-2030)

7.4 Europe OTC Anti-Infective Products Market Size by Application

7.4.1 Europe OTC Anti-Infective Products Sales by Application (2019-2030)

7.4.2 ? Europe OTC Anti-Infective Products Revenue by Application (2019-2030)

7.5 Europe OTC Anti-Infective Products Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China OTC Anti-Infective Products Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China OTC Anti-Infective Products Market Size by Type

8.3.1 China OTC Anti-Infective Products Sales by Type (2019-2030)

8.3.2 China OTC Anti-Infective Products Revenue by Type (2019-2030)

8.4 China OTC Anti-Infective Products Market Size by Application

8.4.1 China OTC Anti-Infective Products Sales by Application (2019-2030)

8.4.2 China OTC Anti-Infective Products Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) OTC Anti-Infective Products Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) OTC Anti-Infective Products Market Size by Type

9.3.1 APAC (excl. China) OTC Anti-Infective Products Sales by Type (2019-2030)

9.3.2 APAC (excl. China) OTC Anti-Infective Products Revenue by Type (2019-2030)

9.4 APAC (excl. China) OTC Anti-Infective Products Market Size by Application

9.4.1 APAC (excl. China) OTC Anti-Infective Products Sales by Application (2019-2030)

9.4.2 APAC (excl. China) OTC Anti-Infective Products Revenue by Application (2019-2030)

9.5 APAC (excl. China) OTC Anti-Infective Products Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America OTC Anti-Infective Products Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America OTC Anti-Infective Products Market Size by Type

10.3.1 Latin America OTC Anti-Infective Products Sales by Type (2019-2030)

10.3.2 Latin America OTC Anti-Infective Products Revenue by Type (2019-2030)

10.4 Latin America OTC Anti-Infective Products Market Size by Application

10.4.1 Latin America OTC Anti-Infective Products Sales by Application (2019-2030)

10.4.2 Latin America OTC Anti-Infective Products Revenue by Application (2019-2030)

10.5 Latin America OTC Anti-Infective Products Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa OTC Anti-Infective Products Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa OTC Anti-Infective Products Market Size by Type

11.3.1 Middle East & Africa OTC Anti-Infective Products Sales by Type (2019-2030)

11.3.2 Middle East & Africa OTC Anti-Infective Products Revenue by Type (2019-2030)

11.4 Middle East & Africa OTC Anti-Infective Products Market Size by Application

11.4.1 Middle East & Africa OTC Anti-Infective Products Sales by Application (2019-2030)

11.4.2 Middle East & Africa OTC Anti-Infective Products Revenue by Application (2019-2030)

11.5 Middle East & Africa OTC Anti-Infective Products Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global OTC Anti-Infective Products Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global OTC Anti-Infective Products Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global OTC Anti-Infective Products Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global OTC Anti-Infective Products Average Sales Price by Manufacturers (2020-2024)

12.2 OTC Anti-Infective Products Competitive Landscape Analysis and Market Dynamic

12.2.1 OTC Anti-Infective Products Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Bayer

13.1.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Bayer OTC Anti-Infective Products Product Portfolio

13.1.3 Bayer OTC Anti-Infective Products Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 GSK

13.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 GSK OTC Anti-Infective Products Product Portfolio

13.2.3 GSK OTC Anti-Infective Products Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Teva

13.3.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Teva OTC Anti-Infective Products Product Portfolio

13.3.3 Teva OTC Anti-Infective Products Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Johnson & Johnson

13.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Johnson & Johnson OTC Anti-Infective Products Product Portfolio

13.4.3 Johnson & Johnson OTC Anti-Infective Products Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 NOVARTIS

13.5.1 NOVARTIS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 NOVARTIS OTC Anti-Infective Products Product Portfolio

13.5.3 NOVARTIS OTC Anti-Infective Products Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Viatris

13.6.1 Viatris Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Viatris OTC Anti-Infective Products Product Portfolio

13.6.3 Viatris OTC Anti-Infective Products Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Sun Pharma

13.7.1 Sun Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Sun Pharma OTC Anti-Infective Products Product Portfolio

13.7.3 Sun Pharma OTC Anti-Infective Products Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 CR SANJIU

13.8.1 CR SANJIU Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 CR SANJIU OTC Anti-Infective Products Product Portfolio

13.8.3 CR SANJIU OTC Anti-Infective Products Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 Cipla

13.9.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Cipla OTC Anti-Infective Products Product Portfolio

13.9.3 Cipla OTC Anti-Infective Products Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.10 Lingrui

13.10.1 Lingrui Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Lingrui OTC Anti-Infective Products Product Portfolio

13.10.3 Lingrui OTC Anti-Infective Products Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 OTC Anti-Infective Products Industry Chain Analysis

14.2 OTC Anti-Infective Products Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 OTC Anti-Infective Products Typical Downstream Customers

14.4 OTC Anti-Infective Products Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Publisher: DIResearch
Choose License
Related Reports

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support